2003 - Antitumour, Pharmacokinetics and distibution studies of diflomotecan admistered and distribution studies of diflomotecan administered intravenously to Nude rats xenografted with human NSCLC H460 lung tumour cells

C. Celmaa, C. Perairea, R. Obacha, F. Bichatb, N. Guilbaudb,

P. Genneband P. Principec
aIpsen Pharma, bOncodesign, cBeaufour Ipsen


By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.